Abstract 2095P
Background
Cancer-related fatigue (CRF) is a significant and frequent problem among cancer patients. There is no gold standard. However, ESMO CPGL 2020 recommended multimodal interventions, CRF is underdiagnosed, undertreated and underdocumented. In this study, we evaluated cancer rehabilitation program including education, physical activity and emotional support.
Methods
Cancer rehabilitation program includes: patients and family education, physical activity (aerobic exercise), water- therapy, yoga, behavioural therapy, relaxation, art, music-therapy, proteinrich nutrition, social support. The Five-time-sit-to-stand test, Hand-Grip-Strength, 6 min walking test, Brief fatigue inventory, Hospital anxiety and Depression scale were used. Descriptive statistics and t-tests.
Results
Participants were 112 patients (48y [29-75]), 60.7% women and 39.2% men. The primary cancer was 26.7 % breast, 16.9% gasrtoesophageal 33.6% colorectal, 16.8% lung, 5.96% pancreatobiliary. Before rehabilitation: the Five-time-sit-to-stand test 10.2 sec (4.5-28.1), Hand-Grip-Strength 28.4 kg, 6 min walking test 482 meters (49,631), Brief fatigue inventory 45 (0-75), Fatique 8/10 (0,10), Cognitive 6, Emotional 4, Physical 6, QoL 4 (0-10). HADS 8 (0, 18). After rehabilitation: the Five-time-sit-to-stand test 5.7 sec (-50%), Hand-Grip-Strength 39.2 kg, 6 min walking test 585 meters (62,822), Brief fatigue inventory 25 (0-58), Fatique 3/10 (0,10), Cognitive 3, Emotional 1, Physical 4, QoL 7 (0-10). HADS 4 (0, 18).
Conclusions
Cancer rehabilitation program including different types of interventions is effective in treating cancer related-fatigue.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06